History of alcohol use disorder: The reduced alcohol cravings observed with GLP-1 medications may feel like a benefit but patients with AUD should discuss any alcohol use with their physician or addiction specialist rather than relying on a pharmacological side effect as their primary support
The results showed that retatrutide at the 8 mg dose reduced total body fat mass by 26.1% at 36 weeks, while the proportion of lean mass lost relative to total weight lost was consistent with other weight loss treatments
Cagrilintide handles appetite suppression through the amylin pathway, while Semaglutide works through GLP-1 receptors
Individuals employed in certain industries, such as the financial and real estate sectors, were also more likely to be prescribed semaglutide compared to people in other jobs such as retail
19 There are multiple problems with the trials assessing the use of rifaximin, 20 such as confounding effects of transjugular intrahepatic portosystemic shunt (TIPS) and surgical portosystemic shunts, 17 randomization imbalance, 21,22 lack of benefit in high risk populations (such as in prevention of HE in those undergoing TIPS), 23 and absence of objective HE scales in outcome assessment in some of the studies
Dysautonomia and Endothelial Dysfunction: By upregulating Heme Oxygenase-1 (HO-1), sulforaphane may protect the delicate endothelial cells lining the blood vessels from oxidative damage, supporting better vascular tone and blood flow regulation in conditions like POTS